Limited Evidence for Parent-of-Origin Effects in Inflammatory Bowel Disease Associated Loci by Fransen, Karin et al.
  
 University of Groningen
Limited Evidence for Parent-of-Origin Effects in Inflammatory Bowel Disease Associated Loci
Fransen, Karin; Mitrovic, Mitja; van Diemen, Cleo C.; Thelma, B. K.; Sood, Ajit; Franke,





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2012
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Fransen, K., Mitrovic, M., van Diemen, C. C., Thelma, B. K., Sood, A., Franke, A., ... Weersma, R. K.
(2012). Limited Evidence for Parent-of-Origin Effects in Inflammatory Bowel Disease Associated Loci. PLoS
ONE, 7(9), [e45287]. https://doi.org/10.1371/journal.pone.0045287
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Limited Evidence for Parent-of-Origin Effects in
Inflammatory Bowel Disease Associated Loci
Karin Fransen1,2., Mitja Mitrovic1,3., Cleo C. van Diemen1, Thelma B. K.4, Ajit Sood5, Andre Franke6,
Stefan Schreiber6,7, Vandana Midha5, Garima Juyal4, Uros Potocnik3,9, Jingyuan Fu1, Ilja Nolte8,
Rinse K. Weersma2*
1Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands, 2Department of Gastroenterology and
Hepatology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands, 3Center for Human Molecular Genetics and Pharmacogenomics,
Medical Faculty, University of Maribor, Maribor, Slovenia, 4Department of Genetics, University of Delhi, South Campus, New Delhi, India, 5Department of Medicine,
Dayanand Medical College and Hospital, Ludhiana, India, 6 Institute for Clinical Molecular Biology, Christian-Albrechts-University, Kiel, Germany, 7Department of General
Internal Medicine, University Clinic Schleswig-Holstein, Kiel, Germany, 8Department of Epidemiology, University of Groningen, University Medical Centre Groningen,
Groningen, The Netherlands, 9 Faculty of Chemistry and Chemical Engineering, University of Maribor, Maribor, Slovenia
Abstract
Background: Genome-wide association studies of two main forms of inflammatory bowel diseases (IBD), Crohn’s disease
(CD) and ulcerative colitis (UC), have identified 99 susceptibility loci, but these explain only ,23% of the genetic risk. Part of
the ‘hidden heritability’ could be in transmissible genetic effects in which mRNA expression in the offspring depends on the
parental origin of the allele (genomic imprinting), since children whose mothers have CD are more often affected than
children with affected fathers. We analyzed parent-of-origin (POO) effects in Dutch and Indian cohorts of IBD patients.
Methods: We selected 28 genetic loci associated with both CD and UC, and tested them for POO effects in 181 Dutch IBD
case-parent trios. Three susceptibility variants in NOD2 were tested in 111 CD trios and a significant finding was re-evaluated
in 598 German trios. The UC-associated gene, BTNL2, reportedly imprinted, was tested in 70 Dutch UC trios. Finally, we used
62 independent Indian UC trios to test POO effects of five established Indian UC risk loci.
Results: We identified POO effects for NOD2 (L1007fs; OR= 21.0, P-value = 0.013) for CD; these results could not be
replicated in an independent cohort (OR= 0.97, P-value = 0.95). A POO effect in IBD was observed for IL12B (OR = 3.2, P-
value = 0.019) and PRDM1 (OR = 5.6, P-value = 0.04). In the Indian trios the IL10 locus showed a POO effect (OR = 0.2, P-
value = 0.03).
Conclusions: Little is known about the effect of genomic imprinting in complex diseases such as IBD. We present limited
evidence for POO effects for the tested IBD loci. POO effects explain part of the hidden heritability for complex genetic
diseases but need to be investigated further.
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Introduction
Crohn’s disease (CD) and ulcerative colitis (UC) are the two
main forms of chronic relapsing inflammatory bowel diseases
(IBD). With a cumulative prevalence of up to 800 per 100,000 in
Europe and 570 in North America [1], it is considered one of the
most common immune-related diseases worldwide. Typically,
from their second or third decade on, patients suffer from a
chronic relapsing inflammation of the gut, which is often
accompanied by extra-intestinal manifestations and complications
that can be extremely debilitating and severe. Treatments are
costly and often insufficient and can be accompanied by severe
side-effects [2]. Hence, there is an urgent need for new therapeutic
targets and curative medication. The pathogenesis is largely
unknown and it is currently thought that an aberrant immune
response to commensal microflora in a genetically susceptible host
underlies the disease [3].
Prior to the introduction of genome-wide association studies
(GWAS), only three loci had been consistently associated with
either form of IBD. Over the past six years, multiple GWAS and
meta-analyses have yielded a lengthening list of variants associated
with CD (71 confirmed independent genetic risk loci) and UC (47
loci) [4,5]. Nevertheless, despite this encouraging progress, as
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much as 77% of the estimated heritability for CD and 72% for UC
is still considered to be unexplained [4,5]. Thus, one of the
challenges in the post-GWAS era is to identify potential sources of
this ‘hidden heritability’ [6], which may reside in associated
variants with lower odds ratios, gene-gene interactions, gene-
environment interactions, and/or structural variation.
In addition, parent-of-origin effects (POO) may comprise a
piece of the missing heritability puzzle in IBD, as suggested by
Akolkar et al. [7]. They show that offspring of mothers with CD
are at higher risk for CD than when fathers are affected. More
recently, Zelinkova et al. showed there was maternal imprinting
and female predominance in familial Crohn’s disease [8]. This
could be explained with at least two distinct types of POO
mechanisms (Fig. 1). If the paternal allele is inactivated by genomic
imprinting, then expression of the locus is determined only by the
maternal allele (Fig. 1a). If this effect is not taken into account,
there may be a significant loss in the statistical power of genetic
association studies [9,10]. Secondly, maternal effects such as diet
or genotype affect the environment for the developing fetus
(Fig. 1b). It is thought that maternal proteins or circulating RNA
passes the placental barrier and may cause changes in the
epigenome of fetal DNA, thereby influence its phenotype.
In this study, we tested for these two types of POO effects in
IBD by using a likelihood ratio test developed by Weinberg [11]. A
previous version of this method (parental asymmetry test) has
already successfully identified a POO effect in another complex
genetic disease, type 1 diabetes [12].
Materials and Methods
Ethical Considerations
This study was approved by the institutional review boards
(Institutional ethical committee, Dayanand Medical College and
Hospital, Ludhiana and Institutional ethical committee, University
of Delhi South Campus; Ethical Review Board of the Medical
Faculty of the Christian-Albrechts-University of Kiel; Institutional
review board, University Medical Centre Groningen, The
Netherlands) of each of the hospitals and written informed consent
was obtained from all subjects personally.
Subjects
All patients were diagnosed according to standard clinical
criteria by endoscopy, radiology and histopathology [13]. A total
of 249 classical offspring-parent trios (one affected offspring with
two unaffected parents) were included in our initial POO analysis.
Of these trios, 115 offspring had CD and 134 had UC. All 115 CD
trios were of western European descent from the Netherlands and
were collected at the IBD Center in the Department of
Gastroenterology and Hepatology, University Medical Center
Groningen (UMCG), the Netherlands. For UC there were 72 trios
of Dutch ancestry (collected at the UMCG) and 62 of Indian
ancestry (collected at Dayanand Medical College and Hospital,
Ludhiana, Punjab, India). Tables 1 and 2 show the clinical
characteristics of the studied cohorts. Genotype data of an
independent replication cohort, consisting of 598 CD parent-
offspring trios from Germany, were obtained for the NOD2
L1007fs variant from the Institute of Clinical Molecular Biology,
Christian-Albrechts-University of Kiel, Germany. These data were
available from a previous study, no phenotypic data is available
[14].
Genotyping and Quality Control
All Dutch and Indian subjects were genotyped using the
Illumina Immunochip (iCHIP) (Illumina Inc., San Diego, Cali-
fornia, United States of America), which is a custom-made
genotyping array that contains ,200,000 single nucleotide
polymorphisms (SNPs) focusing on immune-mediated diseases
[15,16]. Genotyping was performed according to the manufac-
turer’s protocol. Genotyping clusters of the SNPs included in the
current analysis were checked manually using GenomeStudio
software by Illumina Inc. [15,16]. Individuals with a call rate
,95% and/or discordant gender information, and SNPs with a
call rate ,98% were removed from further analysis. Identity-by-
descent analysis by Plink software was used to test for incorrect
family relations (Mendelian errors) in the trios, but no mismatches
were identified.
SNP Selection
For this study we used several strategies to select SNPs. First, to
gain power we pooled the Dutch UC and CD trios and tested for
POO effects in 28 established IBD loci that are both associated to
CD and UC [4]. To avoid losing significance due to multiple
testing correction we tested the 28 overlapping loci instead of all
99 associated risk loci. Variant rs736289 is not present on iCHIP
and no proxy (r2.0.5) could be found. Two variants (rs12261843,
rs181359) were also not captured by iCHIP, but we identified
perfect proxies using SNAP software: rs12261843 was represented
by rs12254167 (r2 = 1; D’ = 1) and rs181359 was represented by
rs2266961 (r2 = 1; D’ = 1) [17]. Second, we aimed to test for the
existence of POO effects in the UC risk SNPs established in
Indians [18]. In addition, we aimed to include SNPs from known
imprinted genes in our analysis. For this, a publicly available
database of known imprinted genes was compared with all 99
IBD-associated loci [19]. The associated locus was defined as the
region of r2.0.5 flanking the most significantly associated SNP,
then extended to the nearest recombination hot-spot, and from
there for an extra 100 kb. Comparison of IBD-associated genes
with the known imprinted genes resulted in the inclusion of one
extra gene, BTNL2; since this is a UC-specific locus it was only
analyzed in the Dutch and Indian UC cohorts. SNP rs9268853 is
the reported UC risk SNP in the Caucasians and was tested in the
Dutch trios, rs3763313 was tested for POO effect in the Indian
trios since this is the reported risk SNP in the Indian population.
Lastly, we included NOD2 since it is the most strongly associated
gene and is most replicated in association studies of CD in
populations of western European descent. Three common disease-
susceptibility variants (G809R, R702W, and L1007fs) were
therefore tested for POO effects in the Dutch CD trios, and
subsequently the L1007fs variant was tested in the German
replication cohort [20].
Statistical Analysis
A power analysis was performed with Quanto software [21] and
showed that in Dutch trios (n = 181) we had more than 80% power
to detect POO effects of OR $3 in variants with MAF $0.025. In
Indian trios (n = 62) we had 80% power to detect POO effects of
OR $3 in variants with MAF $0.075 (see Fig. S1). POO effects
were calculated by a log-likelihood ratio test, which is a statistical
test used to compare the fit of the null hypothesis (i.e. no evidence/
presence of POO in our case) and the alternative hypothesis. The
test is based on the likelihood ratio, which expresses how many
times more likely the data are under one model than the other and
can be used to decide whether to reject the null model in favor of
the alternative model. Weinberg et al. [11] have developed a log-
linear model when a case-parents triad is genotyped and jointly
classified according to the number of copies of a particular allele
carried by the mother, father, and child (denoted as ‘‘M,’’ ‘‘P,’’
and ‘‘C,’’ respectively), there are 15 possible outcomes (i.e. mating
Parental Origin Effects Inflammatory Bowel Disease
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types). The family-specific outcomes (i.e., the cell into which a
particular triad is classified) are independent, provided that each
family contributes only one case. The counts based on classifica-
tion of the triads studied can therefore be thought of as distributed
according to a 15-cell multinomial. The method is based on
consideration of mating types in which the mother and father
carry unequally many copies of the variant allele, with further
stratification on the number of inherited copies of the allele, C.
This second level of conditioning (on C) effectively removes any
effects related jointly to the inherited number of copies and the
Figure 1. Distinct types of parent-of-origin mechanisms tested in this study. Fig. 1a. Genomic imprinting: Genomic imprinting is
characterized by consequent silencing of one allele, depending on the parental origin. In the example shown above a normal situation is displayed on
the left and the genomic imprinting is shown on the right; red is the risk allele and bleu is the wild type allele. The maternal genotype is
heterozygous, the father’s genotype is homozygous wild-type. Offspring in the left scenario have a normal phenotype since the paternal wild-type
allele is expressed in the heterozygous offspring and the mutated allele of the mother is thus rescued by the paternal allele. On the right genomic
imprinting is shown, reflecting the a-term in the method used to test for parent of origin effects. In this example there is a significant genomic
imprinting effect and the OR .1 so the paternal allele is silenced (see materials and methods section statistical analysis). We assume an additive or
recessive model of inheritance. Two possible outcomes are listed, if the offspring inherits the risk allele from the mother and the wild-type allele from
the father is subjected to genomic imprinting, then only the risk allele is expressed, thus the offspring is affected by the mutated allele from the
mother. Fig. 1b. Maternal effects: Maternal effects are effects of the maternal genotype on the fetal phenotype, irrespective of the fetal genotype,
these effects are reflected by the b- and c-terms in the likelihood ratio test that was used to test for parent of origin effects in our study. In the
example given above, the b- and c-terms are significant with an OR.1, meaning that the risk of disease is higher if the mother carries two or one risk
allele respectively. A recessive or co-dominant model is assumed, and higher expression of the mutant allele leads to disease. If the genotype of the
offspring is red, then maternal effects cause increased disease risk and if it is green than the normal population risk applies. If the mother is
homozygous wild-type, no maternal effects occur. If she is homozygous mutant or heterozygous for the risk allele, the offspring is subjected to
maternal effects and thus has an increased disease risk. Note that the wild-type homozygous offspring has a higher disease risk if both parents are
heterozygous.
doi:10.1371/journal.pone.0045287.g001
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parental-allele counts M, P. In short, the method is valid if
inheritance of allele is Mendelian, if there is parental symmetry
within mating types in the population studied, and if the gene
under study is not in linkage disequilibrium with another disease-
susceptibility gene. First, the relative penetration of the risk allele
of the child is established by determining the parental origin of the
risk allele. In the latter, the difference in disease risk is compared
for the varying amounts of risk alleles carried by the mothers; the
genotype of the child is not relevant. The likelihood ratio test
calculates a-, ß-, and c-terms. The a-term indicates the
significance level for genomic imprinting effects: if OR .1, the
risk allele is transmitted more often from the mother to the patient
and if OR ,1 then it is transmitted more often from the father.
The - and c-terms indicate the prenatal effect of the maternal
genotype when the mother carries two risk alleles or one risk allele,
respectively. When the ß- or c-term is significant and OR .1 then
the child has more chance of getting the disease due to maternal
effects. If OR ,1 then the child has less chance of developing the
disease as a consequence of this prenatal effect. Bonferroni
multiple testing corrections were applied to the four different
analyses.
Results
DNA of 249 complete IBD trios was available for our study, of
which four CD (4/115) and two Dutch UC trios (2/72) did not
pass the quality control. Therefore 243 IBD trios (111 CD, 70
Dutch UC & 62 Indian UC) were available for the discovery phase
of the study. Our findings were then replicated in an independent
replication cohort consisting of 598 German CD trios.
Parent-of-origin Analysis in Dutch IBD Trios
A nominally significant genomic imprinting effect was found in
the IL12B gene (a term: P= 0.019; OR=3.2), with OR .1
indicating that the risk allele is more often transmitted from the
mother to the child. In addition, the b term was nominally
significant (p-value = 0.003; OR=0.2) with OR ,1, indicating
that offspring have less chance of getting the disease if their
mothers carry two risk alleles. The PRDM1 gene showed a
nominally significant maternal effect if the mother carried two risk
alleles (b term: p-value = 0.04; OR=5.6), with OR .1 indicating
that the offspring have more chance of getting the disease. The
other tests did not result in significant POO effects. However, none
of these associations were significant after the Bonferroni
correction (table 3).
NOD2 in Dutch and German CD Trios
Three established CD variants in NOD2 (G809R, R702W,
L1007fs) were tested for POO effect in the 111 CD trios [20].
After correcting for multiple testing, a significant genomic
imprinting effect was detected for the L1007fs variant (a term:
p-value = 0.013; OR=21.0). The risk allele was transmitted more
often from the mother than the father. Given the high OR we
aimed to replicate this finding in an independent German cohort
for which NOD2 genotyping data was available. Unfortunately,
our results could not be replicated in this cohort (a term: p-
value = 0.95; OR=0.97) (table 4).
Known Imprinted Gene BTNL2 in Dutch UC Trios
No significant POO effects were detected the established UC
SNP in the BTNL2 locus (rs9268853) in 72 Dutch UC trios
(table 5).
Indian UC Analysis
The established Indian UC SNPs were tested for POO effects in
62 Indian trios [18]. We found a nominally significant genomic
imprinting effect in the IL10 locus (p-value = 0.03; OR=0.16)
where the OR ,1 indicates that the risk allele is more often
transmitted from the father. This association does not, however,
pass the multiple testing correction. This SNP was also tested in
the population of western European descent and we could not
detect any significant imprinting effect. The NOD2 variant that
showed association in the Indian population could not be tested for
POO effects since only homozygous wild-type fathers were
available, hence all the trios were uninformative (table 6).
Discussion
For the first time parent-of-origin effects have been tested in
IBD on a genetic level for the overlapping IBD-associated loci. We
found limited evidence that POO effects exist in IBD in the Dutch
population for IL12B, PRDM1 and NOD2 in our discovery cohort,
but the large POO effect for NOD2 could not be replicated in an
independent German replication cohort. Moreover, we found a
nominally significant POO effect in IL10 in our Indian population.
Although the results from the Dutch trios might be false-positive,
Table 1. Phenotypic characterization of subjects with Crohn’s disease.
Cohort Number of trios No. of males (%) AOO Ileal Colonic Ileocolon Upper GI
Dutch CD 115 39 (34%) 24 23 28 64 11
German CD 598 N/A N/A N/A N/A N/A N/A
doi:10.1371/journal.pone.0045287.t001
Table 2. Phenotypic characterization of subjects with ulcerative colitis.
Cohort Number of trios No. of males (%) AOO Proctitis Left-sided Extended Unknown
Dutch UC 72 30 (42%) 25 8 19 38 5
Indian UC 62 45 (73%) 28 22 15 20 5
N/A not available, AOO average age of onset. Cases and disease location are given according to the Montreal classification. for CD L1, L2, L3 and L4; for UC E1, E2, E3. No
phenotypic information was available for the German cohort.
doi:10.1371/journal.pone.0045287.t002
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they imply that the paternal allele has been silenced and thus does
not increase the disease risk in all genes for which we found a
POO effect. This is consistent with results from epidemiological
studies that show that IBD is transmitted to offspring more often
from the mother than the father.
NOD2 is the most strongly associated and most consistently
replicated CD gene. Here we observed a genomic imprinting
Table 3. Results of the parent-of-origin (POO) analysis of Dutch IBD Trios (n = 181) for the 28 known SNPs shared between
ulcerative colitis and Crohn’s disease.
SNP Gene RA p-a OR-a p-ß OR-ß p-c OR-c
rs11209026 IL23R G 0.6 0.6 1.0 1.6 1.0 1.0
rs7554511 KIF21B C 0.2 1.7 0.5 0.7 0.6 0.8
rs3024505 IL10 A 0.4 1.5 0.4 0.5 0.3 1.5
rs7608910 REL G 0.4 0.7 0.7 0.8 0.8 0.9
rs2310173 IL1R2 T 0.5 1.4 0.3 0.5 0.7 0.9
rs3197999 MST1 A 0.5 0.8 0.6 1.4 0.3 1.4
rs6451493 PTGER4 T 0.1 2 0.5 1.6 0.4 1.6
rs6871626 IL12B1 A 0.019 3.2 0.003 0.2 0.2 0.6
rs6556412 IL12B1 A 1.0 1.0 0.9 1.0 0.9 0.9
rs6908425 CDKAL1 C 0.5 0.7 0.8 0.8 0.6 0.7
rs6911490 PRDM1 T 0.2 0.5 0.04 5.6 0.6 1.2
rs10758669 JAK2 C 1.0 1.0 0.2 0.5 0.8 0.8
rs4246905 TNFSF15 C 0.8 0.9 0.8 0.8 0.8 0.9
rs10781499 CARD9 A 0.8 1.0 0.5 0.7 0.4 0.8
rs12254167 CREM CCNY* N/A 0.1 0.5 0.6 1.4 0.3 1.4
rs10761659 ZNF365 G 0.4 1.4 0.8 0.9 0.9 0.9
rs6584283 NKX2-3 T 0.3 0.6 0.4 1.6 0.1 1.9
rs2155219 C11orf30 T 0.1 0.5 0.3 1.8 0.6 1.2
rs17293632 SMAD3 T 0.2 1.8 0.1 0.4 0.3 0.7
rs2872507 ORMDL3 A 0.8 0.9 0.3 1.7 0.6 1.2
rs1893217 PTPN2 G 0.1 2.1 0.7 1.2 0.3 0.7
rs12720356 TYK2 C 0.6 1.4 0.5 0.5 0.9 0.9
rs2297441 RTEL1-SLC2A4RG A 0.7 0.8 0.9 1.1 0.9 0.9
rs1297265 intergenic A 0.9 1.1 0.3 1.7 0.3 1.5
rs2836878 intergenic G 0.6 1.3 0.9 0.9 0.6 1.3
rs2838519 ICOSLG G 0.7 0.8 0.3 1.7 0.8 0.9
rs2266961 YDJC* N/A 0.9 1.0 0.8 0.8 0.5 0.8
P-value (p-a; ß; c) and odds ratio (OR-a; ß; c) of the alpha-, beta-, and gamma-terms. Alpha-term indicates the genomic imprinting effect; Beta-term and gamma-term
indicate the maternal effect in case the mother carries respectively two and one risk alleles. N/A not available. Significant associations are shown in bold. P-values
displayed in the table are not corrected for multiple testing. *reported SNP not present/captured by the Immunochip, a proxy was used, therefore no risk allele could be
reported. r2 = 1; 1r2 = 0.03; two independent hits in one gene.
doi:10.1371/journal.pone.0045287.t003
Table 4. Results of the parent-of-origin (POO) analysis for the NOD2 variants in Dutch Crohn’s disease trios (n = 111) and
replication in German Crohn’s disease trios (n = 598).
SNP Gene p-a p-a replication OR-a p-ß p-ß replication OR-ß p-c p-c replication OR-c
G908R NOD2 0.1 9.0 N/A* N/A* 0.2 0.3
R702W NOD2 0.4 2.3 1.0 0 0.2 0.4
L1007fs NOD2 0.01e 0.9 21.0 1.0 1.0 7.7 0.1 0.8 0.2
P-value (p-a; ß; c) and odds ratio (OR-a; ß; c) of the alpha-, beta-, and gamma-terms. P-value of the replication study (p- a; -ß; - c replication ) of the alpha-, beta-, and
gamma-terms. Alpha-term indicates the genomic imprinting effect; Beta-term and gamma-term indicate the maternal effect in case the mother carries respectively two
and one risk alleles. Significant associations are in bold.
eSignificant after Bonferroni multiple testing correction. P-values displayed in the table are not corrected for multiple testing.
*No homozygous mothers are available for beta-term analysis.
doi:10.1371/journal.pone.0045287.t004
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effect for the L1007fs mutation in Dutch CD trios, yet we failed to
replicate this in an independent German cohort. The results in our
initial analysis might be a false-positive finding, although we had
sufficient power to detect effects in the Dutch trios. Although both
cohorts were of western European descent, we question whether
population specific and environmental factors might play a major
role in POO effects and explain part of the lack of replication. We
will further elaborate on this later in the discussion. TheL1007fs
mutation seems to have a predominant role in CD families since
recently it has been shown in a case report that all family members
were carrying the mutation and had CD [22]. Moreover in cases
of homozygosity this variant will lead to ileal stenosis [23,24],
implying a strong effect of the L1007fs mutation on the disease
phenotype.
Our results suggest a possible contradictory effect of the two
types of POO effects we studied for the IL12B gene both with a
nominal significance. The genomic imprinting analysis (a-term)
showed inheritance of the disease risk from the mother, while the
analysis of independent maternal effect showed protection for
disease if the mother carries two risk alleles (b-term). This suggests
that the maternal risk allele is expressed and causes a higher
disease risk, but simultaneously and independently, if the mother
carries two risk alleles the child has a lower risk for IBD due to in
utero effects on the fetus. IL12B resides on the established and
consistently replicated IBD locus on chromosome 5q33 and it
encodes a sub-unit of IL23, which is involved in Th17/IL23R
signaling. This pathway has been implicated in several chronic,
immune-related diseases such as psoriasis, rheumatoid arthritis,
and ankylosing spondylitis [25,26,27].
The PRDM1 gene showed a nominally significant maternal
effect in the POO analysis in the population of western European
descent when mothers carried two risk alleles; the OR of 5.6
supports results from others that IBD is more often transmitted
from the mother than the father. The environment in which the
fetus develops causes changes that increase the risk for CD.
PRDM1 has been associated to several immune-related diseases,
but also to various types of lymphomas [28,29,30,31]. It encodes a
protein that represses the expression of the b-interferon gene.
Hypothetically, if the maternal effect causes altered expression of
PRDM1, an aberrant immune response could increase CD risk.
In the Indian trio study we found a nominally significant
genomic imprinting effect for the IL10 locus. In contrast to the
findings in the population of western European descent, the risk
allele was more often transmitted from the father to the child. No
epidemiological studies of the Indian population are available to
validate the paternal transmission. We could not replicate the
POO effects from the Dutch population in the Indian trios nor vice
versa. This might indicate that POO effects are population specific.
Later in the discussion we will discuss this in further detail.
Weinberg’s method to detect POO effect is a robust one.
Moreover it takes genomic imprinting and maternal effects into
consideration simultaneously. It therefore has less power than the
standard parental asymmetry test (PAT) that only tests for genomic
imprinting, but PAT is invalid if maternal effects are present [11].
The importance of these maternal effects has been shown in mice,
with a knockout of the serotonin 1A receptor gene leading to an
anxiety-like phenotype. Implantation of wild-type embryos into
knockout mothers and cross-fostering of the pups with wild-type
mothers showed the full anxiety-phenotype, indicating that the
maternal genotype influences the phenotype and that this effect
persists after birth [32]. This is supported by our evidence for
maternal effects in the PRDM1 and IL12B loci.
We do not know why POO effects occur. Humans are diploid
organisms and as such, can survive the, on average, 500 recessive
mutations that are present in every human being, since most
deleterious effects are rescued by the other allele [33]. Genomic
imprinting significantly deduces diploidy by consequently inacti-
vating one haplotype depending on its parental origin and thus
impairing the rescue mechanism. The most cited and best
supported hypothesis for the existence of this counter-intuitive
phenomenon is the parental conflict hypothesis, in which both
sexes have a need to pass on their genetic information to the next
generation. Yet this does not explain the existence of genomic
imprinting in immune-related genes, for example [34]. Hypothet-
ically, to prevent adverse reactions passing from mother to fetus, it
Table 5. Results of the parent-of-origin (POO) analysis in the BTNL2 locus in Dutch UC ulcerative colitis trios (n = 72).
SNP Gene RA p-a OR-a p-ß OR-ß p-c OR-c
rs9268853 BTNL2 T 1.0 1.0 0.7 0.7 0.6 0.6
P-value (p-a; ß; c) and odds ratio (OR-a; ß; c) of the alpha-, beta-, and gamma-term. Alpha-term indicates the genomic imprinting effect; Beta-term and gamma-term
indicate the maternal effect in case the mother carries respectively two and one risk alleles. Significant associations are in bold. P-values displayed in the table are not
corrected for multiple testing.
doi:10.1371/journal.pone.0045287.t005
Table 6. Results of the parent-of-origin (POO) analysis in Indian UC trios (n = 62).
SNP Gene RA p-a OR-a p-ß OR-ß p-c OR-c
rs6426833 RNF186 A 0.2 0.3 0.2 4.3 0.1 4.8
rs3024505 IL10 A 0.03 0.16 0.8 1.3 0.5 1.5
rs3763313 BTNL2 T 0.8 0.8 1.0 2.0 1.0 4.0
rs2395185 HLA-DRA A 0.3 2.3 0.8 1.3 0.4 3.0
P-value (p-a; ß; c) and odds ratio (OR-a; ß; c) of the alpha-, beta-, and gamma-term. Alpha-term indicates the genomic imprinting effect; Beta-term and gamma-term
indicate the maternal effect in case the mother carries respectively two and one risk alleles. Significant associations are in bold. P-values displayed in the table are not
corrected for multiple testing.
doi:10.1371/journal.pone.0045287.t006
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is important that the immune responses are alike and thus
preferably maternal immune genes are expressed.
In our study we had sufficient power (.80%) to detect POO
effects with an OR of three or higher for each SNP in our study.
By adding more tests the significance level must be adjusted
accordingly and the power to detect differences is lower. Therefore
we chose to only test the 28 overlapping IBD risk loci in a pooled
cohort of Dutch CD and UC trios instead of all 99 risk loci.
Consequently, bigger cohorts are needed to test the remaining
IBD loci for POO effects.
None of our findings in one population could be replicated in
another population. At least three reasons could explain this fact.
First, it might be that the initial findings are false positive findings:
the cohorts have a limited size and thus more variation around the
mean, resulting in a higher chance of false positive findings.
Second, it is unknown for how long genomic imprinting effects are
stable in humans. It has been shown from mouse studies that
genomic imprinting is stable for at least 3 generations [35]. No
data is available in human studies. Moreover, genomic imprinting
was shown to be influenced by environmental factors [36,37],
which could mean that although the imprinting mechanism is
global, distinct genes may be imprinted in different populations
because they were exposed to distinct environmental effects. The
latter two could indicate that even within populations different
imprinting effects occur.
In conclusion, we aimed to identify genomic imprinting effects
and maternal effects acting on the risk alleles of IBD and we
showed, for the first time, that IL12B, NOD2 and PRDM1might be
involved in these phenomena in Dutch IBD trios. It has already
been shown that POO effects exist in type 1- and type 2 diabetes,
which like IBD are complex genetic disorders and show a
substantial overlap of disease susceptibility loci with IBD [10,12].
Given the high OR in NOD2 we sought to replicate our findings,
but could not confirm the POO effect for NOD2 in an independent
German replication cohort. In the Indian population we did
identify POO effects in the IL10 gene. We could neither replicate
our findings from the Dutch trios in the Indian or in the German
population nor our findings from the Indian population in the
Dutch cohort. This suggests that POO effects are either false-
positive findings or prone to be population specific. We anticipate
that future investigations, using larger, multi-ethnical cohorts will
help to shed light on these complex and currently little known
relationships. Parent-of-origin effects can take various forms and
are not restricted to imprinting, but may involve a variety of
mechanisms including gender effects, epistasis, epigenetic effects,
and environmental influences during pre- or postnatal develop-
ment. Better understanding of such effects will probably require
detailed studies of model organisms in which breeding and
environment can be carefully controlled. Given that alleles
identified through GWAS account for a relatively small fraction
of heritability, parent of origin effects may underlie some of the
missing heritability problem. With appropriate family-based study
designs data analysis methods and international collaborative
efforts it will be possible to screen for parent of origin effects across
the entire genome. In addition, epigenetic profiling on a genome
scale will likely lead to the identification of novel epigenetic marks
in a variety of disorders that may provide a bridge among the
parental genome, parental environment, and offspring phenotype.
We anticipate that the investigations of alternative models of
inheritance, appropriate study design and application of novel
technologies will enable a more complete picture of heritability in
human traits, leading to new insights in the field of genetics of
complex diseases.
Supporting Information
Figure S1 Power analysis of a. the Dutch trio analysis
(181 trios) and b. the Indian trios (62 trios). S1a. Power
calculation of the Dutch trio analysis: The power is shown on the
x-axis, the different odds ratios (OR) are shown on the y-axis. The
different lines represent SNPs with different minor allele
frequencies. In red, the regular 80% power cut-off is shown. With
an OR of 3, we have sufficient power to detect parent-of-origin
effects in SNPs with a MAF of 2.5%. S1b. Power calculation of the
Indian trio analysis: The power is shown on the x-axis, the
different odds ratios (OR) are shown on the y-axis. The different
lines represent SNPs with different minor allele frequencies. In
red, the 80% power cut-off is shown. With an OR of 4, we have
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